The change of renal functions after nonvitamin K oral anticoagulants in patients with atrial fibrillation

Rahman, 2014, Global epidemiology of atrial fibrillation, Nat Rev Cardio, 11, 639, 10.1038/nrcardio.2014.118 Friberg, 2013, Atrial fibrillation prevalence revisited, J Intern Med, 274, 461, 10.1111/joim.12114 Wong, 2017, Epidemiology of atrial fibrillation: The Australian and Asia-Pacific perspective, Heart Lung Circ, 26, 870, 10.1016/j.hlc.2017.05.120 Lau, 2016, Atrial fibrillation and thromboembolism in patients with chronic kidney disease, J Am Coll Cardiol, 68, 1452, 10.1016/j.jacc.2016.06.057 Kulkarni, 2012, Chronic kidney disease and atrial fibrillation: A contemporary overview, J Afib, 5, 62 Chao, 2015, Risk of ischemic stroke and stroke prevention in patients with atrial fibrillation and renal dysfunction, J Afib, 8, 62 Zeng, 2015, Risk of thromboembolic events in atrial fibrillation with chronic kidney disease, Stroke, 46, 157, 10.1161/STROKEAHA.114.006881 Hart, 2007, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Ann Intern Med, 146, 857, 10.7326/0003-4819-146-12-200706190-00007 Sergey, 2011, Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate, Kidney International, 80, 181, 10.1038/ki.2011.44 Wheeler, 2016, Anticoagulation-related nephropathy, J Thromb Haemost, 14, 461, 10.1111/jth.13229 Vinay, 2015, Oral Anticoagulants and Risk of Nephropathy, Drug Saf, 38, 527, 10.1007/s40264-015-0290-z Chatrou, 2012, Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists, Blood Rev, 26, 155, 10.1016/j.blre.2012.03.002 Brodsky, 2018, Anticoagulant-Related Nephropathy, J Am Soc Nephrol, 29, 2787, 10.1681/ASN.2018070741 Golbin, 2017, Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases, Clinical Kidney Journal, 10, 381, 10.1093/ckj/sfw133 Schurgers, 2012, Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype, PloS One, 7, 10.1371/journal.pone.0043229 Brodsky, 2017, Acute kidney injury aggravated by treatment initiation with apixaban: Another twist of anticoagulant-related nephropathy, Kidney Res Clin Pract, 36, 387, 10.23876/j.krcp.2017.36.4.387 Abt, 2000, Thin basement membrane disease and acute renal failure secondary to gross hematuria and tubular necrosis, Am J Kidney Dis, 35, 533, 10.1016/S0272-6386(00)70209-5 Ruff, 2014, Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials, Lancet, 383, 955, 10.1016/S0140-6736(13)62343-0 Michael, 2015, Changes in Renal Function in Patients With Atrial Fibrillation - An Analysis from the RE-LY Trial, J Am Coll Cardiol, 65, 2481, 10.1016/j.jacc.2015.03.577 Yi-Hsin, 2016, Acute Kidney Injury in Asians With Atrial Fibrillation Treated with Dabigatran or Warfarin, J Am Coll Cardiol, 68, 2272, 10.1016/j.jacc.2016.08.063 Ziad, 2016, Efficacy and Safety of Apixaban Compared with Warfarin in Patients with Atrial Fibrillation in Relation to Renal Function Over Time - Insights from the ARISTOTLE Randomized Clinical Trial, JAMA Cardiol., 1, 451, 10.1001/jamacardio.2016.1170 Christopher, 2016, On-treatment Outcomes in Patients With Worsening Renal Function with Rivaroxaban compared with Warfarin - Insights From ROCKET AF, Circulation, 134, 37, 10.1161/CIRCULATIONAHA.116.021890 Xiaoxi, 2017, Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation, J Am Coll Cardiol, 70, 2621, 10.1016/j.jacc.2017.09.1087 Andrew SL, Lesley AI, Kunihiro M, et al. GFR Decline as an End Point for Clinical Trials in CKD. Am J Kidney Dis.64(6):821-835 Steffel, 2018, The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation, Eur Heart J, 00, 1